RECOVER, NCT05200754: Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19 |
|
|
| Recruiting | 2 | 174 | Europe | Convalescent/Vaccine-boosted Plasma (CP/PVP) | Carsten Müller-Tidow, German Federal Ministry of Education and Research, Institut für Klinische Transfusionsmedizin und Zelltherapie Heidelberg gGmbH | SARS-CoV-2 Infection | 04/22 | 06/22 | | |